F
Über
Frans van Dalen is a Founding Partner at Meneldor, bringing over 30 years of experience in the (bio)pharmaceutical industry. Since 1992, he has been a founding partner of the Synthon group of companies, contributing to its growth to over 1,500 employees across nine global locations. He played a central role in the development, regulatory strategy, manufacturing, and commercialization of generic medicines, biosimilars, and novel biological entities. His expertise enables him to identify high-potential technologies early and guide companies through pharmaceutical development, from discovery through approval and market entry.
Schwerpunkte
BioTech, BioPharma
Verifizierte Kontakte & Outreach Agenten
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...